Peter Martin Hjørnet Kamper

5PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

|Apr 01, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Ninja Övergaard, Kjersti Lia, Jeremia Collin

|Jan 21, 2026
Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Sophie-Charlott Seidenfaden, Thomas Graversgaard Adams, Peter Kamper

|Dec 03, 2024
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.

Maja Dam Andersen, Katharina Wolter, Marie Hairing Enemark

|Oct 26, 2018
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.

Jonas Juul Hansen, Hans Beier Ommen, Lars Christian Gormsen

Pageof 1

Frequent Collaborators

2 joint publications

Daniel Molin

1 joint publications

Maja Dam Andersen

1 joint publications

Katharina Wolter

1 joint publications

Marie Hairing Enemark